炎症
免疫学
免疫系统
疾病
B细胞
细胞
自然杀伤性T细胞
调节性B细胞
T细胞
生物
医学
抗体
内科学
遗传学
作者
Meritxell Nus,Dimitrios Tsiantoulas,Ziad Mallat
标识
DOI:10.1016/j.ejphar.2017.09.002
摘要
Atherosclerosis is a leading cause of death worldwide. It is a complex chronic inflammatory disease involving interactions between vascular, circulating and immune cells. B cells play an important role in chronic inflammation producing antibodies and regulating T and natural killer (NKT) cell activation. The role of B cells in atherosclerosis is complex, with atherogenic and protective roles assigned for distinct B cell subsets. Drugs that deplete B cells or modulate their functions are now used in the treatment of various autoimmune diseases in humans. Here, we briefly review the roles of B cell subsets in atherogenesis, and emphasize the potential impact of B cell targeted therapies on the cardiovascular risk of treated patients. Developing more B cell subset-specific therapies would lead to more effective treatments with enhanced safety profile.
科研通智能强力驱动
Strongly Powered by AbleSci AI